The award recognizes a significant paper by Cui in Cell Death and Differentiation.
Five faculty members in the School of Medicine have been named the 2016 class of James A. Pittman Jr., M.D., Scholars, a program organized to recognize the contributions of junior faculty and support the retention of highly competitive scientists and physician-scientists.
UAB and UMass researchers have uncovered a new mechanistic understanding of potential treatment for genetic disorders.
Improved production of stem cells is vital if they are to achieve their promise for medical research and disease treatments like transplantation, creating patient-specific cell-replacement therapies to treat neurological diseases, heart ailments, blood diseases and diabetes.
Greater efficiency is a must for future clinical use of these cells in regenerative medicine, drug screening and disease study.
David M. Bedwell, Ph.D., professor in the Department of Microbiology and associate director of the Gregory Fleming James Cystic Fibrosis Center, has been named the interim chair of the UAB Department of Biochemistry and Molecular Genetics.
UAB-led research shows how methylating an RNA binding protein leads to alternative RNA splicing. Mutant enzymes are often found in blood cancers.
Researchers have received funding to seek and validate biomarkers for the progressive, inherited disease Friedreich’s ataxia, a life-shortening degenerative neuromuscular disorder.
UAB researchers discover a new protein interaction from the 1918 flu strain that may help influenza circumvent the host immune response that would fight viral infection.